Sudeep Pharma IPO Sees 16% GMP Jump as Grey Market Prices Surge

Grey-market premium for Sudeep Pharma’s IPO jumps 16%, signaling a likely listing price much above its issue band.

Live Market Updates

Latest Financial News

positive

Sudeep Pharma IPO Sees 16% GMP Jump as Grey Market Prices Surge

Sudeep Pharma IPO Sees 16% GMP Jump as Grey Market Prices Surge
Ahead of its IPO opening on 21 November, Sudeep Pharma is commanding a ~16% grey-market premium (GMP), indicating strong demand. The GMP surge suggests a likely listing price of around ₹688 per share-approximately ₹95 above the upper price band of ₹593. 
This reflects investor confidence in the company’s growth story, underpinned by its global excipient business and manufacturing capabilities.
Companies:
  • Sudeep Pharma
Tags:
  • ipo
  • india